Table 2.

Classification based on baseline diagnostic parameter (BP and blood sugar)—patients with coexistent triple disease

Parameter	Patient count (%)
Systolic BP (n = 345,314)
< 120 mm Hg	37,734 (10.93)
120–130 mm Hg	57,547 (16.67)
130–140 mm Hg	79,315 (22.97)
140–180 mm Hg	155,822 (45.13)
≥ 180 mm Hg	148,96 (4.32)
Diastolic BP (n = 343,660)
< 80 mm Hg	97,492 (28.37)
80–90 mm Hg	150,151 (43.7)
90–120 mm Hg	94,671 (27.55)
≥ 120 mm Hg	1346 (0.4)
HbA1c (n = 107,576)
< 5.7%	2367 (2.21)
5.7–6.5%	13,143 (12.22)
6.5–7%	13,152 (12.23)
7–8%	26,238 (24.4)
8–9%	18,885 (17.56)
9–10%	12,794 (11.9)
≥ 10%	20,997 (19.52)
RBS (n = 52,027)
< 200 mg/dl	26,889 (51.69)
≥ 200 mg/dl	25,138 (48.32)
FBS (n = 131,948)
< 126 mg/dl	52,954 (40.14)
≥ 126 mg/dl	78,994 (59.87)
PPBS (n = 116,196)
< 200 mg/dl	54,606 (47)
≥ 200 mg/dl	61,590 (53)

BP blood pressure, FBS fasting blood sugar, HbA1c glycated hemoglobin, n number of patients, PPBS postprandial blood sugar, RBS random blood sugar